Biocon Limited has informed the Exchange regarding a press release dated July 24, 2023, titled "Biocon Biologics Announces Positive CHMP Opinion for YESAFILI��, Biosimilar Aflibercept ".
Biocon Limited has informed the Exchange regarding a press release dated July 24, 2023, titled "Biocon Biologics Announces Positive CHMP Opinion for YESAFILI��, Biosimilar Aflibercept ".